HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Masana Selected Research

Caloric Restriction

1/2013Body weight loss by very-low-calorie diet program improves small artery reactive hyperemia in severely obese patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Masana Research Topics

Disease

6Atherosclerosis
03/2016 - 10/2000
4Cardiovascular Diseases (Cardiovascular Disease)
10/2023 - 12/2001
3Insulin Resistance
10/2007 - 11/2000
2Inflammation (Inflammations)
01/2019 - 12/2001
2Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2016 - 11/2007
2Overweight
01/2015 - 09/2014
2Obesity
11/2007 - 10/2007
1Neoplasms (Cancer)
01/2018
1Non-alcoholic Fatty Liver Disease
03/2016
1Hypertriglyceridemia
03/2016
1Fatty Liver
03/2016
1Pleural Effusion (Pleural Effusions)
01/2016
1Pneumonia (Pneumonitis)
01/2016
1Acute-Phase Reaction
01/2016
1Bicuspid Aortic Valve Disease
10/2015
1Weight Loss (Weight Reduction)
01/2013
1Hyperemia
01/2013
1Body Weight (Weight, Body)
01/2013
1Carotid Artery Diseases
07/2012
1Type 2 Diabetes Mellitus (MODY)
10/2007
1HIV Infections (HIV Infection)
09/2006
1Rheumatoid Arthritis
12/2001
1Hyperlipidemias (Hyperlipidemia)
03/2001
1Whooping Cough (Pertussis)
03/2001
1Coronary Artery Disease (Coronary Atherosclerosis)
02/2001
1Thrombasthenia (Glanzmann Thrombasthenia)
01/2001
1Coronary Disease (Coronary Heart Disease)
11/2000
1Alzheimer Disease (Alzheimer's Disease)
08/2000
1Hyperlipoproteinemia Type IV (Type IV, Hyperlipoproteinemia)
07/2000

Drug/Important Bio-Agent (IBA)

6LipidsIBA
01/2018 - 08/2000
5Lipoproteins (Lipoprotein)IBA
03/2014 - 02/2001
4Biomarkers (Surrogate Marker)IBA
01/2016 - 10/2007
4ApolipoproteinsIBA
10/2015 - 07/2000
3Glucose (Dextrose)FDA LinkGeneric
09/2014 - 10/2000
3Triglycerides (Triacylglycerol)IBA
11/2007 - 08/2000
3Insulin (Novolin)FDA Link
11/2007 - 10/2000
2oxidized low density lipoproteinIBA
10/2023 - 03/2001
2LDL CholesterolIBA
10/2023 - 10/2015
2HDL CholesterolIBA
03/2016 - 01/2016
2CholesterolIBA
09/2014 - 08/2000
1Transcription Factors (Transcription Factor)IBA
01/2019
1AdipokinesIBA
01/2018
1palmitoleic acidIBA
03/2016
1AntioxidantsIBA
01/2015
1Lipid PeroxidesIBA
11/2007
12,4-thiazolidinedione (thiazolidinedione)IBA
11/2007
1C-Reactive ProteinIBA
11/2007
1AdiponectinIBA
11/2007
1Fatty Acid-Binding ProteinsIBA
11/2007
1Retinol-Binding Proteins (Retinoid Binding Proteins)IBA
10/2007
1ChemokinesIBA
09/2006
1Phospholipases A2 (Phospholipase A2)IBA
12/2001
1LDL Lipoproteins (beta Lipoproteins)IBA
12/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2001
1Messenger RNA (mRNA)IBA
09/2001
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
03/2001
1Lipase (Acid Lipase)FDA Link
02/2001
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
02/2001
1Protein Kinase CIBA
01/2001
1ThrombinFDA Link
01/2001
1Fibrinogen (Factor I)FDA Link
01/2001
1CalciumIBA
01/2001
1Apolipoproteins E (ApoE)IBA
08/2000
1VLDL LipoproteinsIBA
07/2000

Therapy/Procedure

1Mediterranean Diet
12/2014
1Caloric Restriction
01/2013
1Therapeutics
03/2001